Navigation Links
New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting
Date:6/2/2008

se events included fatigue, hand/foot syndrome and skin rash.

The lead investigator for this study is Joan Schiller, MD, professor and chief of the hematology/oncology division at the University of Texas Southwestern and Andrea L. Simmons distinguished chair in cancer research, Dallas, TX. (abstract #8014).

Thyroid Cancer

A Phase 2 Study of Sorafenib in Metastatic Thyroid Carcinoma

Findings from this single-arm Phase 2 study showed that treatment with Nexavar resulted in meaningful anti-tumor activity in the majority of patients with encouraging overall clinical benefit (disease stabilization and partial responses) in patients with advanced thyroid cancer. In the study, Nexavar was well-tolerated; the most common treatment-related adverse events included fatigue, rash, diarrhea, palmer-plantar erythema, musculoskeletal pain and weight loss. Patients enrolled in this study had been diagnosed with metastatic, iodine-refractory, unresectable or locally-advanced thyroid cancer.

The lead investigator for this study is Marcia S. Brose, MD, PhD, assistant professor, director of cancer genetics laboratory, University of Pennsylvania Health System, Philadelphia, PA. (abstract #6026).

Gastrointestinal Stromal Tumors

Activity of Sorafenib in Patients with Imatinib and Sunitinib-Resistant Gastrointestinal Stromal Tumors (GIST): A Phase 2 Trial of the University of Chicago Phase 2 Consortium

Findings from this single-arm Phase 2 study suggest that Nexavar is active and well tolerated in patients with Gleevec or Gleevec and Sutent resistant GIST. The most common treatment-emergent adverse events included hand-foot syndrome, hypertension, rash and diarrhea.

The lead investigator for this study is Lauren Wiebe, MD, fellow, University of Chicago, Chicago, IL. (abstract #10502).

Gastric/GEJ

A Phase 2 Study: Combination of Sorafenib with Docetaxel and Cisplatin in the Treatment of Metastatic or Advanced Unres
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals, Inc.; OnyxPharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study
2. Nexavar First FDA-Approved Drug Therapy for Liver Cancer
3. ZymoGenetics Reports Positive Phase 1 Results for IL-21 With Nexavar(R)
4. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
5. Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting
6. Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments
7. New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer
8. Data To Be Presented at ASCO Supports Potential of Peregrines Cotara(R) for the Treatment of Brain Cancer
9. About 60 Clinical Studies Regarding Schering-Ploughs Oncology Compounds Will be Presented at ASCO
10. Two DOXIL(R) Studies to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
11. Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 24, 2013  Auxilium Pharmaceuticals, Inc. (Nasdaq: ... in the Deutsche Bank Health Care Conference to be ... Mr. Adrian Adams , Chief Executive ... of the Company and its product pipeline at 12:00 ... (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) The presentation ...
(Date:5/24/2013)... 24, 2013 The potential of ... delivery of therapeutic agents has been receiving undeniable attention ... showing significant promise. The crucial formulation considerations for orally ... play a major role in the efficiency of pulmonary ... development of new formulation techniques and devices in recent ...
(Date:5/23/2013)... May 23, 2013  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... named the 2013 Life Science Firm of the Year by ... Vanda was honored at the TCM,s 25 th Annual ... Maryland.  The Tech Awards Celebration recognizes the leaders and innovators ... Maryland and the surrounding regions. ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2
... ... , ... - Will Use BrainTrack,s College Campus Data to Enhance Elsevier Evolve,Website Registrations ... technical and,medical information products and services, and BrainTrack,( http://www.braintrack.com ), the widely referenced ...
... 8 ARKRAY, Inc., a global leader of human ... announced an exclusive distribution agreement with scil animal care ... a global organization focused on providing high quality veterinary ... will be to re-introduce the SPOTCHEM(TM) EZ, a small ...
Cached Medicine Technology:Elsevier Selects BrainTrack Directory as Supplier of College Data 2Elsevier Selects BrainTrack Directory as Supplier of College Data 3Elsevier Selects BrainTrack Directory as Supplier of College Data 4ARKRAY, Inc. Announces Partnership With scil animal care company for the SPOTCHEM(TM) EZ Analyzer 2
(Date:5/24/2013)... 2013 The creative flair and design ... University (PolyU)'s Institute of Textiles and Clothing (ITC) have ... Fashion Show held on 22 May at The Mira ... of ITC design students, various knitwear producers and yarn ... collections of four outfits from 20 graduating students majoring ...
(Date:5/24/2013)... 23 (HealthDay News) -- Certain statins -- the ... chances of developing type 2 diabetes, a new ... patients taking atorvastatin (brand name Lipitor), rosuvastatin (Crestor) ... Focusing on almost 500,000 Ontario residents, researchers in ... diabetes were low in patients prescribed statins. Still, ...
(Date:5/24/2013)... National Geographic questioned in an article on ... is getting lost in the swirl of summer kickoff. ... some research and analysis on the subject based on publicly ... evaluation of around 180 ecards shared by Americans, suggests that ... of fun and celebration. In the modern era of ...
(Date:5/24/2013)... Texas (PRWEB) May 24, 2013 This ... 2022” provides an overview of the risk factors and ... (8MM) (US, France, Germany, Italy, Spain, UK, Australia, and ... cases of meningococcal disease segmented by age (<1, 1–4, ... (B, C, Y, and W-135) in these markets. The ...
(Date:5/24/2013)... May 24, 2013 Just about any bodyweight ... Mike Whitfield, a trainer based in Dallas, GA that uses ... there’s one pushup that is not used enough. , “The ... make the standard pushup more challenging. By keeping your hands ... and the abs are being worked much harder than a ...
Breaking Medicine News(10 mins):Health News:PolyU Stages Knitwear Fashion Show 2Health News:Could Statins Raise Diabetes Risk? 2Health News:Could Statins Raise Diabetes Risk? 3Health News:Is Memorial Day More Than A Three-Day Weekend 2Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 2Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 3Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 4Health News:Medicine Ball Pushups, a Unique Bodyweight Chest Exercise, Released in Video from BodyweightTorch.com 2
... By Kathleen Doheny HealthDay Reporter , TUESDAY, June ... levels does not reduce the odds of cardiovascular disease for ... of heart problems, as researchers have known. But it may ... , , Strict control of blood sugar in a certain ...
... ... Medical Design and Manufacturing Exposition in New York City, MDEA winning products were celebrated in ... Hand Hygiene System was named a gold award winner in the category of general hospital ... ...
... Conducting a ... time and money, and reduce post-implementation problems. Let PBG take the worries out of ... ... -- Once a hardware or software system is installed, it must be properly maintained to ...
... decreased drastically over the last few decades, we still have ... President, J. Fred Ralston, Jr., MD, FACP, said as a ... Control and Prevention, ACP called for a comprehensive federal strategy ... taken by states currently. "A comprehensive tobacco control and ...
... had lower rates of mammography screening than middle-class women, ... "Health insurance is a necessary condition for ... said Nasar Ahmed, Ph.D., chair of epidemiology and biostatistics ... Social Work at Florida International University. Ahmed was ...
... bans in two large Minnesota cities was not associated with ... to higher employment in restaurants, according to new research. ... of clean indoor air policies on bars and restaurants as ... published studies of the economic impact of smoking bans, this ...
Cached Medicine News:Health News:Tight Blood Sugar Control in Older Diabetics May Not Reduce Heart Risk 2Health News:Tight Blood Sugar Control in Older Diabetics May Not Reduce Heart Risk 3Health News:Xhale Innovation's HyGreen Hand Hygiene System Brings Home the Gold 2Health News:PBG Offers a Pre-Upgrade Site Survey for Ericom, VMware, and NetApp Upgrades 2Health News:Internists outline comprehensive federal strategy to control tobacco use 2Health News:Counseling increased mammography use among low-income women with health insurance 2Health News:Bars, restaurants see no significant employment change under smoking bans in 2 cities 2Health News:Bars, restaurants see no significant employment change under smoking bans in 2 cities 3Health News:Bars, restaurants see no significant employment change under smoking bans in 2 cities 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: